Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
DUBLIN, Jan. 22, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission...
DUBLIN, Jan. 22, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission...
Nicole Jeray, a WUN Board Member and Pro-Golfer, recently was featured in Oprah Magazine in...
A Wake Up Narcolepsy funded study was published in Behavioral Sleep Medicine, it is Dr....
Merck Pharmaceuticals is seeking participants for a study that involves discontinuation of treatment for excessive...
We are EXCITED to share with you all the 2020 Boston Marathon® WUNner team! Wake...
Has the cold weather got you already dreaming of the summer? Well, we have something...
IDEO is working with a pharmaceutical company to re-think and re-design the experience of taking...
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage...
Wake Up Narcolepsy launched a WUN Narcolepsy Awareness Apparel Fundraiser in conjunction with their 2019...